Menu
Back to User profile » Dr Shurui Zhao
Papers published by Dr Shurui Zhao:
Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
Li G, Wang T, Zhang X, Zhao S, Wang Y, Wu J, Peng S, Zhao M
Drug Design, Development and Therapy 2020, 14:2187-2197
Published Date: 3 June 2020
13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein
Li G, Ren Y, Zhang X, Zhao S, Wang Y, Wu J, Peng S, Zhao M
OncoTargets and Therapy 2019, 12:10651-10662
Published Date: 5 December 2019
RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
Liu W, Mao Y, Zhang X, Wang Y, Wu J, Zhao S, Peng S, Zhao M
International Journal of Nanomedicine 2019, 14:7263-7279
Published Date: 6 September 2019
Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
Zhao S, Li Z, Huang F, Wu J, Gui L, Zhang X, Wang Y, Wang X, Peng S, Zhao M
International Journal of Nanomedicine 2019, 14:4817-4831
Published Date: 3 July 2019
Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
Wu J, Zhu H, Yang G, He J, Wang Y, Zhao S, Zhang X, Gui L, Zhao M, Peng S
International Journal of Nanomedicine 2018, 13:1139-1158
Published Date: 26 February 2018
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation
Wu JH, Zhao M, Wang YJ, Wang YN, Zhu HM, Zhao SR, Gui L, Zhang XY, Peng SQ
Drug Design, Development and Therapy 2017, 11:225-239
Published Date: 17 January 2017
RGD(F/S/V)-Dex: towards the development of novel, effective, and safe glucocorticoids
Jiang X, Zhao M, Wang Y, Zhu H, Zhao S, Wu J, Song Y, Peng S
Drug Design, Development and Therapy 2016, 10:1059-1076
Published Date: 8 March 2016
Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy
Jiang X, Wang Y, Zhu H, Wang Y, Zhao M, Zhao S, Wu J, Li S, Peng S
Drug Design, Development and Therapy 2015, 9:2329-2342
Published Date: 22 April 2015